Download Amaurosis Fugax

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Amaurosis Fugax
Essentials for the Ophthalmic Practitioner
Amaurosis fugax
 Amaurosis – darkening, obscure
 Fugax – fugitive
AF and stroke: Statistical evidence
 Strokes per year in US: 700,000
 ≈ 30% are recurrent stroke
 25% mortality
 TIA and AF: greatest risk of stroke is 1st week*
 TIA and AF: 10.5% risk of stroke in 90 days*
* Rothwell,PM, et.al. Timing of TIAs preceding stroke: time window for
prevention is very short. Neurology. 2005;64:817-820
AF vision loss
 Transient (1-10 min)
 Partial to total loss
 Often begins in upper field
 Painless
 Unilateral (except if vertebrobasilar insuff.)
 Commonly no precipitating factor
 Fully reversible (w/in minutes, hrs)
AF – Outline for course discussion
I. Thromboembolism
II. Non-embolic, hemodynamic causes of AF
III. Masqueraders of true AF
IV. In-office examination
V. Primary auxiliary testing
VI. Optometric Management
VII. Medical, surgical treatment considerations
I.
Thromboembolism - ICA
Factors associated with higher risk of stroke
 ICA stenosis of 80-94%
 Age >75
 Male gender
 History of hemispheric TIA or stroke
 History of intermittent claudication
 Absence of collateral circulation
- Benavente,O.,et.al. Prognosis after transient monocular blindness associated with
carotid artery stenosis N Engl J Med. 2001 Oct 11;345(15):1084-90
Thromboembolism carotid sinus
 Biopathology of hemodynamic shear stress
 Greatest plaquing: carotid sinus outer wall
 Flow stasis = low shear stress = intimal proliferation
 Shear stress = atheroprotective endothelial response
Thromboembolism vertebral – basilar arteries
 Brain stem ischemia
 Homonymous vision symptoms
 Dipl, cortical blindness
 Vertigo, disequilibrium
 Dysphasia, dysarthria
 Medical management
 Endovascular surgery
Thromboembolism cardiac
 20% ischemic strokes
 Often calcific
 Atrial fibrillation
 Valve disease
 Prosthetic valves
 Cardiomyopathy
Thromboembolic disease Patent foramen ovale
Nearly half (43%) of young patients (<50yrs) with cryptogenic ischemic stroke in this
study have a patent foramen ovale.
MesaD, et.al. Prevalence of patent foramen ovale in young patients with cerebral
ischemic accident of unknown origin Rev Esp Cardiol. 2003 Jul;56(7):662-8
Other conditions with clot risk
 Pregnancy; birth control pills
 Sickle cell
 Hypercoagulable conditions
 Mostly pediatric, young adult
 Inherited thrombophilias
 Protein C, Protein S deficiencies
 Factor V Leiden (blood clotting protein)
 Antithrombin III deficiency
II.











Hemodynamic cause
Relative retinal, ON
vascular insufficiency
Generalized atherosclerosis →
Rapid drop in CRA pressure
Induced by
Exercise
Bright lt./brightness intolerance
Postural changes / hypotensive episodes
Low cardiac output
ECA, ICA, ophthalmic artery high grade stenosis
Takayasu’s disease
 Hyperviscosity conditions
 Gaze-induced AF secondary to orbital tumor
 ICA dissection
50% pts w/ dissection and stroke have no history of antecedent neck trauma
- BassiP, et.al. Cervical cerebral artery dissection: A multicenter prospective study.
Neurol Sci. 2003;24 (suppl 1): S4-S7
 Carotid aneurysm
Idiopathic cause
 No identifiable lesion or hemodynamic cause
 Vasospastic? Migraine?
III. Ocular presentations w/ transient blur
 Transient obscurations
 Papilledema,  intracranial pressure
 “graying out” of vision / seconds / rarely total loss
 Occult ION
 Malignant hypertension
 Prodrome of CRVO
 Optic neuritis
 Compression of ON, optic chiasm
Other “sudden loss of vision” considerations
 Glaucoma / extreme  IOP
 Vitreous hemorrhage
 Vitreous floaters
 Hyphema
 “Overnight” cataract or PCO
 Corneal decompensation, edema
 Numerous others
IV.
In-office examination
Detailed CC, history
BP; pulse; cervical and heart auscultation
Neurologic eye testing
SLE
Ophthalmoloscopy
o Retinal edema; hemorrhage
o Disc edema; pallor
o Arteriole attenuation; emboli
 Ocular ischemic syndrome
 Hypoperfusion syndrome; rubeosis
 ODM – measure CRA pressure
o Digital ODM w/ contralateral comparison
 Exophthalmometry – r/o orbital disease
Prospective study
 145 pts. over 3 years referred for Doppler studies due to eye signs, symptoms






Predictive value of identifying significant ICA stenosis
- 20.0% positive with amaurosis fugax
- 18.2% positive with Hollenhorst plaque(s)
- 20.0% positive with hypoperfusion retinopathy
- other eye findings demonstrated poor predictive value
- McCullough, HK, et.al.; Ocular findings as predictors of carotid artery occlusive
disease: is carotid imaging justified? J Vasc Surg. 2004 Aug;40(2):279-86
V. Primary auxiliary tests
Laboratory
 Sed rate and CRP (abnl >30mm/hr; >0.9mg/dL)
 CBC w/ differential
 Platelets (ref. range 150,000-350,000/mm3)
 Lipid panel (lipoproteins, cholesterol, triglycerides)
 Glycosylated Hb and FBS
 Homocysteine if elevated: 2X RR of stroke
 Antinuclear antibody (Lupus)
 Anti-phospholipid antibody
Study
Antiphospholipid Ab testing in 368 patients over 3.5 years with ophthalmic occlusive
disease
-86 patients tested positive (23.4%) vs. 5% general pop.
-CRVO = 18% APA positive; BRVO = 24%
-CRAO = 22% APA positive; BRAO = 32%
-AION = 23%
- Palmowski-Wolfe, AM, et.al.;Antiphospholipid antibodies in ocular arterial and venous
occlusive disease Ophthalmologica. 2007;221(1):41-6
Cerebrovascular studies
 Noninvasive Doppler ultrasound
 B-mode ultrasound
 Direct view
 Color Doppler
 Trickle flow, “string sign”
 Duplex
 Subclavian steal: vertebral, subclavian
Retrospective study in the UK covering 3 years of consecutive eye clinic patients referred
for carotid Doppler
 55% were positive for ICA stenosis
 20% had >70% stenosis
- Mukherji,W.et.al. Indications and outcome of carotid Doppler ultrasound: an
ophthalmic perspective. Eur J Ophthalomol. 2004 May-Jun;14(3):240-4
Transcranial Doppler
 Pulsed
 Intracranial blood directionality, velocity
 Ophthalmic artery: antegrade? Retrograde? Steal phenomenon?
Magnetic resonance angiography
 Noninvasive
 Time-of-flight technology, excellent for blood flow evaluation
Arteriography
 “Gold standard”
 Risks
Cardiac studies
Echocardiography identified a potential cardiac or proximal aortic source for embolism in
16 / 73 (21.9%) of patients; including 8 who also had atrial fibrillation and ICA stenosis
>50%.
8/73 (11.0%) had lesions only detected by ECG.
-Mouradian,M, et.al.;Echocardiographic findings of patients with retinal ischemia or
embolism J Neuroimaging 2002 Jul;12(3):219-23
VI.








Optometric management
Identify and manage if ocular cause
Glaucoma, BRVO, hyphema, vitreous hemorrhage, etc.
Measure BP, pulse, auscultation
Stat ESR and CRP (r/o occult GCA)
Individualize suspicion and focus of examination
Age
Health and family history
Communicate with family practitioner!
o Phone call same day; written report
 Laboratory; hematology tests
 Temporal artery biopsy if  CRP,  ESR, and GCA suspected
 Duplex/Doppler ultrasound; cerebrovascular studies
 Echocardiogram; cardiac studies
 ASA /anti-platelet option
Management concerns
 Misdiagnosis of symptoms and working dx
 Underestimate urgency of situation
 No follow-up w/ primary care physician or patient
 Diagnosis delay: referral to an inappropriate subspecialist
How would YOU manage the AF patient?
- Questionnaire sent to 1,600 GPs; 54% response
 72% would refer pt. to specialist
 36% would start anti-thrombotic treatment
- Donders,RC, et.al.;How do general practitioners diagnose and manage
patients with transient monocular loss of vision of sudden onset? J Neurol. 1999
Dec;246(12):1145-50
VII. Surgical treatment: high grade stenosis
= of proximal ICA
North American Symptomatic Carotid Endarterectomy Trial (NASCET)
Carotidendarterectomy (CEA) advised if >70% stenosis and symptomatic:
- Stroke risk: 9% in 2 years if surgery
- Stroke risk: 26% in 2 years if medical management
Symptomatic moderate ICA stenosis (50-69%) had a 5-year rate of ipsilateral stroke:
- 15.7% surgically treated (CEA)
- 22.2% medically treated
Symptomatic ICA stenosis of <50% no benefit from CEA
- Barnett,HG, et.al.(NASCET Collaborators); Benefit of carotid endarterectomy in
patients with symptomatic moderate or severe stenosis; N Engl J Med. 1998 Nov
12;339(20):1415-25
ICA angioplasty and stenting
 Controversial
 Long term results pending
 More controlled studies
 Surgeon dependent
 Primary advantage is local anesthetic
 Catheter with balloon
 Metal-mesh stent
Treatment – medical intervention
 Prevention of ischemic stroke
 Meta-analysis of randomized 21 trials
 Antiplatelet treatment
o 28% RR reduction – nonfatal stroke
o 16% RR reduction – fatal stroke
- Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomized
trials of antiplatelet therapy for prevention of death, MI, and stroke in high risk patients.
BMJ 2002; 324:71-86
Case presentations